| Sign In to gain access to subscriptions and/or personal tools. |
Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and PolandDepartment of General Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany, bernhard.greve{at}uni-tuebingen.de
Department of General Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany
Department of Neurology, University of Pecs, Hungary
Department of Neurology, University of Pecs, Hungary
Department of General Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany
Department of Neurology, Laboratory of Neuroimmunology, Medical University of Lodz, Poland
Department of Neurology, Laboratory of Neuroimmunology, Medical University of Lodz, Poland
Department of Neurology, Jahn Ferenc Teaching Hospital, Budapest, Hungary
Department of Immunogenetics, National Medical Center, Budapest, Hungary
Institute of Anthropology and Human Genetics, University of Tübingen, Germany
Institute of Epidemiology and Social Medicine, University of Münster, Germany
Department of General Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany Polymorphisms in the CTLA4 gene region have been associated with susceptibility to autoimmune diseases. The recently described single nucleotide polymorphism CT60, located in the 3' untranslated region of CTLA4 is associated with Graves' disease, thyroiditis, autoimmune diabetes and other autoimmune diseases. A case-control association study was conducted in German, Hungarian and Polish multiple sclerosis (MS) patients and regional control individuals for the CTLA4 CT60 and +49A/G polymorphisms. No significant association of these polymorphisms or respective haplotypes with MS was found. No association of CT60 genotypes with T cell expression of ICOS and CTLA-4 after in vitro stimulation was detected. Multiple Sclerosis 2008; 14: 153—158. http://msj.sagepub.com
Key Words: association CTLA-4 genetics multiple sclerosis polymorphism
This version was published on March
1, 2008 Multiple Sclerosis, Vol. 14, No. 2,
153-158 (2008) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||